Evidence map›Paper›PMID 42824121›Full record

ArticleFrontiers in endocrinology2026

Late-onset atypical pseudohypoparathyroidism type 1A with intracranial calcification and epilepsy associated with a novel

Daiping Hua, Shang Xiang, Xianfeng Yu, Jingjing Wu, Yequn Wang, Wenming Yang, Han Wang

Abstract readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daiping Hua *Department of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Shang Xiang *Department of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Xianfeng Yu *Department of Neurology, Taixing Second People's Hospital, Taizhou, China.
Jingjing WuDepartment of Neurology, The Fifth Affiliated Hospital of Anhui University of Chinese Medicine, Lu'an, China.
Yequn WangDepartment of Neurology, The Fifth Affiliated Hospital of Anhui University of Chinese Medicine, Lu'an, China.
Wenming YangDepartment of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Han WangDepartment of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudohypoparathyroidism (PHP) type 1A is a rare inherited disorder characterized by resistance to parathyroid hormone and, typically, features of Albright hereditary osteodystrophy. We report a late-onset case in a 59-year-old woman who presented with cognitive decline, behavioral and psychiatric symptoms, gait instability, and seizure-like episodes. Laboratory tests showed hypocalcemia, hyperphosphatemia, and elevated parathyroid hormone levels. Brain imaging revealed symmetrical calcifications in the bilateral basal ganglia, thalami, and periventricular regions, while electroencephalography showed epileptiform discharges. Genetic testing identified a heterozygous missense variant in

Indexed as

Brain DiseasesCalcinosisChromograninsEpilepsyGTP-Binding Protein alpha Subunits, GsPseudohypoparathyroidismFemaleHumansMiddle AgedMutation, MissenseChromograninsGNAS protein, humanGTP-Binding Protein alpha Subunits, Gscognitive impairmentepilepsyFahr syndromeGNAS geneintracranial calcificationpseudohypoparathyroidism

Identifiers

PMID42824121
PMCPMC13627021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.